| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Regulatory Officer
1 company
Wentworth Kerry is a Chief Regulatory Officer at NUVB. Recent filings cover 2 purchases and 3 sales. Those positions are worth an estimated $155K at current prices.
Wentworth Kerry's largest disclosed position is in NUVB as Chief Regulatory Officer, worth about $155K. The recent filings there lean toward selling, a net 249,750 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | NUVB Nuvation Bio Inc. | Chief Regulatory Officer | Sale+OE10b5-1 | 63,000 | $6.02 | $379,190.70 | -54.3% | +0.5% | - | |
| Apr 17, 2026 | NUVB Nuvation Bio Inc. | Chief Regulatory Officer | Sale+OE10b5-1 | 36,750 | $5.01 | $184,279.20 | -40.9% | +11.0% | - | |
| Apr 6, 2026 | NUVB Nuvation Bio Inc. | Chief Regulatory Officer | Sale+OE10b5-1 | 200,000 | $4.52 | $903,560.00 | -79.1% | +25.8% | - | |
| Jun 16, 2025 | NUVB Nuvation Bio Inc. | Chief Regulatory Officer | Buy | 50,000 | $1.79 | $89,740.00 | New | +69.4% | +164.5% |